Call 20 : Vaccine development and manufacture / Academia and industry united innovation and treatment for tuberculosis

IMI2 – Call 20

"topic 2 : Innovations to accelerate vaccine development and manufacture"
"TOPIC 3 : Academia and industry united innovation and treatment for tuberculosis (UNITE4TB)"

Publication date :                                     21 January 2020
Stage 1 submission deadline:                 Extended to 12 May 2020
Stage 2 submission deadline:                 Extended to 19 November 2020
Submission and evaluation process:      2 stages
Action type:                                              Research and Innovation Action (RIA) 

Update 08/04/2020: The deadline for submitting short proposals has been extended to 12 May 2020.

topics: 

• Topic 1: Early diagnosis, prediction of radiographic outcomes and development of rational, personalised treatment strategies to improve long-term outcomes in psoriatic arthritis.

• Topic 2: Innovations to accelerate vaccine development and manufacture.

• Topic 3: Academia and industry united innovation and treatment for tuberculosis (UNITE4TB)
  This topic is part of the IMI AMR Accelerator Programme. Applicants should also read the Questions and Answers on the programme (document last updated November 2019).

• Topic 4: Tumour plasticity

• Topic 5: Proton versus photon therapy for oesophageal cancer – a trimodality strategy

• Topic 6: Handling of protein drug products and stability concerns

full details of the topics, including the budget breakdown and the General Conditions for the Call for proposals, ARE AVAILABLE on the IMI website.